Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

4,6,4’–trimethylangelicin

EU orphan designation number: EU/3/13/1137   
Active ingredient: 4,6,4’–trimethylangelicin
Indication: Treatment of cystic fibrosis
Sponsor: Rare Partners srl Impresa Sociale
Corso Magenta 31, 20123 Milano, Italia

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
21/06/2013 Centralised Orphan - Designation EMA/OD/017/13 (2013)3959 of 19/06/2013